MIDAZOLAM ACCORD midazolam (as hydrochloride) 5 mg/ 5 mL solution for injection syringe Australië - Engels - Department of Health (Therapeutic Goods Administration)

midazolam accord midazolam (as hydrochloride) 5 mg/ 5 ml solution for injection syringe

accord healthcare pty ltd - midazolam, quantity: 5 mg - injection, solution - excipient ingredients: hydrochloric acid; sodium chloride; sodium hydroxide; water for injections - iv as an agent for conscious sedation prior to short surgical, diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography and cardiac catheterisation, either alone or in conjunction with a narcotic; iv for induction of anaesthesia, preliminary to administration of other anaesthetic agents. with the use of a narcotic premedicant, induction of anaesthesia can be attained with a narrower dose range and in a shorter period of time. iv for sedation in intensive care units; intermittent administration or continuous infusion. im for preoperative sedation (induction of sleepiness or drowsiness and relief of apprehension) and to impair memory of perioperative events.

MIDAZOLAM ACCORD midazolam (as hydrochloride) 50 mg/10 mL solution for injection syringe Australië - Engels - Department of Health (Therapeutic Goods Administration)

midazolam accord midazolam (as hydrochloride) 50 mg/10 ml solution for injection syringe

accord healthcare pty ltd - midazolam, quantity: 50 mg - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid; sodium chloride - iv as an agent for conscious sedation prior to short surgical, diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography and cardiac catheterisation, either alone or in conjunction with a narcotic; iv for induction of anaesthesia, preliminary to administration of other anaesthetic agents. with the use of a narcotic premedicant, induction of anaesthesia can be attained with a narrower dose range and in a shorter period of time. iv for sedation in intensive care units; intermittent administration or continuous infusion. im for preoperative sedation (induction of sleepiness or drowsiness and relief of apprehension) and to impair memory of perioperative events.

B. BRAUN MIDAZOLAM midazolam (as hydrochloride) 50 mg/10 mL Solution for Injection ampoule Australië - Engels - Department of Health (Therapeutic Goods Administration)

b. braun midazolam midazolam (as hydrochloride) 50 mg/10 ml solution for injection ampoule

b braun australia pty ltd - midazolam hydrochloride, quantity: 5.56 mg/ml (equivalent: midazolam, qty 5 mg/ml) - injection, solution - excipient ingredients: hydrochloric acid; water for injections; sodium chloride - iv as an agent for conscious sedation prior to short surgical, diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography and cardiac catheterisation, either alone or in conjunction with a narcotic; iv for induction of anaesthesia, preliminary to administration of other anaesthetic agents. with the use of a narcotic premedicant, induction of anaesthesia can be attained with a narrower dose range and in a shorter period of time; iv for sedation in intensive care units; intermittent administration or continuous infusion; im for preoperative sedation (induction of sleepiness or drowsiness and relief of apprehension) and to impair memory of perioperative events.

B. BRAUN MIDAZOLAM midazolam (as hydrochloride) 5 mg/5 mL Solution for Injection ampoule Australië - Engels - Department of Health (Therapeutic Goods Administration)

b. braun midazolam midazolam (as hydrochloride) 5 mg/5 ml solution for injection ampoule

b braun australia pty ltd - midazolam hydrochloride, quantity: 1.112 mg/ml (equivalent: midazolam, qty 1 mg/ml) - injection, solution - excipient ingredients: hydrochloric acid; sodium chloride; water for injections - iv as an agent for conscious sedation prior to short surgical, diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography and cardiac catheterisation, either alone or in conjunction with a narcotic; iv for induction of anaesthesia, preliminary to administration of other anaesthetic agents. with the use of a narcotic premedicant, induction of anaesthesia can be attained with a narrower dose range and in a shorter period of time; iv for sedation in intensive care units; intermittent administration or continuous infusion; im for preoperative sedation (induction of sleepiness or drowsiness and relief of apprehension) and to impair memory of perioperative events.

B. BRAUN MIDAZOLAM midazolam (as hydrochloride) 5 mg/1 mL Solution for Injection ampoule Australië - Engels - Department of Health (Therapeutic Goods Administration)

b. braun midazolam midazolam (as hydrochloride) 5 mg/1 ml solution for injection ampoule

b braun australia pty ltd - midazolam hydrochloride, quantity: 5.56 mg/ml (equivalent: midazolam, qty 5 mg/ml) - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium chloride - iv as an agent for conscious sedation prior to short surgical, diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography and cardiac catheterisation, either alone or in conjunction with a narcotic; iv for induction of anaesthesia, preliminary to administration of other anaesthetic agents. with the use of a narcotic premedicant, induction of anaesthesia can be attained with a narrower dose range and in a shorter period of time; iv for sedation in intensive care units; intermittent administration or continuous infusion; im for preoperative sedation (induction of sleepiness or drowsiness and relief of apprehension) and to impair memory of perioperative events.

B. BRAUN MIDAZOLAM midazolam (as hydrochloride) 15 mg/3 mL Solution for Injection ampoule Australië - Engels - Department of Health (Therapeutic Goods Administration)

b. braun midazolam midazolam (as hydrochloride) 15 mg/3 ml solution for injection ampoule

b braun australia pty ltd - midazolam hydrochloride, quantity: 5.56 mg/ml (equivalent: midazolam, qty 5 mg/ml) - injection, solution - excipient ingredients: water for injections; sodium chloride; hydrochloric acid - iv as an agent for conscious sedation prior to short surgical, diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography and cardiac catheterisation, either alone or in conjunction with a narcotic; iv for induction of anaesthesia, preliminary to administration of other anaesthetic agents. with the use of a narcotic premedicant, induction of anaesthesia can be attained with a narrower dose range and in a shorter period of time; iv for sedation in intensive care units; intermittent administration or continuous infusion; im for preoperative sedation (induction of sleepiness or drowsiness and relief of apprehension) and to impair memory of perioperative events.

NITROPRUSSIDE-EMC sodium nitroprusside 50 mg/2 mL concentrated injection vial Australië - Engels - Department of Health (Therapeutic Goods Administration)

nitroprusside-emc sodium nitroprusside 50 mg/2 ml concentrated injection vial

emcure pharmaceuticals pty ltd - sodium nitroprusside, quantity: 50 mg - injection, concentrated - excipient ingredients: water for injections - sodium nitroprusside concentrated injection is indicated for: ,1. immediate reduction of blood pressure in patients with hypertensive crises. concomitant oral antihypertensive medication should be started while the hypertensive emergency is being brought under control with sodium nitroprusside. ,2. producing controlled hypotension during anaesthesia in order to reduce bleeding in surgical procedures where surgeon and anaesthetist deem it appropriate. ,3. short term therapy of cardiac failure, to enhance cardiac output and lower myocardial oxygen requirements. patients should be commenced on oral therapy as soon as possible.

NITROPRUSSIDE SXP sodium nitroprusside 50mg/2mL concentrated injection vial Australië - Engels - Department of Health (Therapeutic Goods Administration)

nitroprusside sxp sodium nitroprusside 50mg/2ml concentrated injection vial

southern xp ip pty ltd - sodium nitroprusside, quantity: 25 mg/ml - injection, concentrated - excipient ingredients: water for injections - nitroprusside sxp concentrated injection is indicated for:,1. immediate reduction of blood pressure in patients with hypertensive crises. concomitant oral antihypertensive medication should be started while the hypertensive emergency is being brought under control with sodium nitroprusside.,2. producing controlled hypotension during anaesthesia in order to reduce bleeding in surgical procedures where surgeon and anaesthetist deem it appropriate.,3. short term therapy of cardiac failure, to enhance cardiac output and lower myocardial oxygen requirements. patients should be commenced on oral therapy as soon as possible.

Timlatan 50 micrograms/ml + 5 mg/ml eye drops, solution Ierland - Engels - HPRA (Health Products Regulatory Authority)

timlatan 50 micrograms/ml + 5 mg/ml eye drops, solution

bausch + lomb ireland limited - latanoprost; timolol maleate - eye drops, solution - 50mcg/ml + 5 milligram(s)/millilitre - beta blocking agents1); timolol, combinations